Literature DB >> 11689796

Repeat heart valve surgery: risk factors for operative mortality.

J M Jones1, H O'kane, D J Gladstone, M A Sarsam, G Campalani, S W MacGowan, J Cleland, G W Cran.   

Abstract

BACKGROUND: Patients undergoing repeat heart valve operations are a diverse population. We assessed risk factors for operative mortality in patients undergoing a first heart valve reoperation.
METHODS: A retrospective review of hospital records was performed for 671 patients who underwent first repeat heart valve operations between 1969 and 1998. Univariable and multivariable analyses were performed.
RESULTS: Operative mortality was 8.6%. Mortality fell each decade to 4.8% in the most recent period (adjusted chi(2) for linear trend P <.0005). Mortality increased from 3.0% for reoperation for a failed repair or reoperation at a new valve site to 10.6% for prosthetic valve dysfunction or periprosthetic leak and to 29.4% for endocarditis or valve thrombosis. Concomitant coronary artery bypass grafting was associated with a mortality of 15.4% compared with 8.2% when it was not required. Mortality for aortic valve replacement was 6.4%, mitral valve replacement 7.4%, aortic and mitral valve replacement 11.5%, tricuspid valve replacement 25.6%, periprosthetic leak repair 9.1%, and isolated valve repair 2.2%. Among 336 patients requiring replacement of prosthetic valves, mortality was 26.1% for replacement of a mechanical valve compared with 8.6% for replacement of a tissue valve (P <.0005). Multivariable analyses identified year of reoperation, age, coronary artery bypass grafting, indication, and replacement of a mechanical valve rather than a tissue valve as significant explanatory variables for operative mortality.
CONCLUSIONS: Heart valve reoperations can be performed with an acceptable operative mortality. However, we have identified several categories of patients in whom reoperation carries an increased risk.

Entities:  

Mesh:

Year:  2001        PMID: 11689796     DOI: 10.1067/mtc.2001.116470

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  50 in total

1.  Heart failure due to prosthetic mitral leaflet thrombosis.

Authors:  Umar Hamid Imran; Alan Soo; Carol Wilson; Alastair Graham
Journal:  BMJ Case Rep       Date:  2011-04-18

2.  Transcatheter Edwards Sapien XT valve in valve implantation in degenerated aortic bioprostheses via transfemoral access.

Authors:  Martin Greif; Philipp Lange; Helmut Mair; Christoph Becker; Christoph Schmitz; Gerhard Steinbeck; Christian Kupatt
Journal:  Clin Res Cardiol       Date:  2012-06-23       Impact factor: 5.460

3.  Patient-specific simulations of transcatheter aortic valve stent implantation.

Authors:  C Capelli; G M Bosi; E Cerri; J Nordmeyer; T Odenwald; P Bonhoeffer; F Migliavacca; A M Taylor; S Schievano
Journal:  Med Biol Eng Comput       Date:  2012-02       Impact factor: 2.602

Review 4.  Case study and review: treatment of tricuspid prosthetic valve thrombosis.

Authors:  David Yi Zhang; Jay Lozier; Richard Chang; Vandana Sachdev; Marcus Y Chen; Jennifer L Audibert; Keith A Horvath; Douglas R Rosing
Journal:  Int J Cardiol       Date:  2011-10-14       Impact factor: 4.164

5.  Replacement of a Björk-Shiley Delrin aortic valve still functioning after 25 years.

Authors:  M Ismail Badak; Erdem Ali Ozkisacik; Mehmet Boga; Ugur Gurcun; Berent Discigil
Journal:  Tex Heart Inst J       Date:  2004

6.  Analysis of mitral valve replacement outcomes is enhanced by meaningful clinical use of electronic health records.

Authors:  John C Chen; Thomas Pfeffer; Shelley Johnstone; Yuexin Chen; Mary-Lou Kiley; Richard Richter; Hon Lee
Journal:  Perm J       Date:  2013

7.  Second and third cardiac valve reoperations: factors influencing death and long-term survival.

Authors:  Mehmet Erdem Toker; Ercan Eren; Mustafa Guler; Kaan Kirali; Mehmet Yanartas; Mehmet Balkanay; Cevat Yakut
Journal:  Tex Heart Inst J       Date:  2009

Review 8.  Transcatheter valve-in-valve implantation versus reoperative conventional aortic valve replacement: a systematic review.

Authors:  Kevin Phan; Dong-Fang Zhao; Nelson Wang; Ya Ruth Huo; Marco Di Eusanio; Tristan D Yan
Journal:  J Thorac Dis       Date:  2016-01       Impact factor: 2.895

Review 9.  Wireless and battery-free platforms for collection of biosignals.

Authors:  Tucker Stuart; Le Cai; Alex Burton; Philipp Gutruf
Journal:  Biosens Bioelectron       Date:  2021-01-23       Impact factor: 10.618

10.  Outcomes of reoperative aortic valve replacement after previous sternotomy.

Authors:  Damien J LaPar; Zequan Yang; George J Stukenborg; Benjamin B Peeler; John A Kern; Irving L Kron; Gorav Ailawadi
Journal:  J Thorac Cardiovasc Surg       Date:  2009-12-16       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.